Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 3Hodgkin Disease 3Mycosis Fungoides 2Lymphoma 2Recurrence 1Lymphomatoid Papulosis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Disease 1Dermatitis, Contact 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 48fludarabine phosphate 32Peripheral Blood Stem Cell Transplantation 32Whole-Body Irradiation 26Etoposide 23Mycophenolic Acid 22Rituximab 20Filgrastim 18Doxorubicin 18Vincristine 16Cyclosporine 16Busulfan 16Tacrolimus 15Prednisone 15Methotrexate 13Melphalan 13Antilymphocyte Serum 12Cytarabine 11Radiotherapy 10Carboplatin 10Bortezomib 9romidepsin 8Ifosfamide 8Cord Blood Stem Cell Transplantation 8Methylprednisolone 7Lenalidomide 7Flow Cytometry 7Brentuximab Vedotin 7Sirolimus 6Everolimus 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma, Large-Cell, Anaplastic × Mechlorethamine × Clear all
NCT05106192 2025-06-12

Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.

Case Comprehensive Cancer Center

Phase NA Withdrawn
DermatologicLymphoid

Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphomatoid Papulosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡